2020
DOI: 10.1038/s10038-019-0714-1
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in TOMM70 lead to multi-OXPHOS deficiencies and cause severe anemia, lactic acidosis, and developmental delay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
27
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 30 publications
2
27
0
Order By: Relevance
“…Homozygous null drosophila models of patient mutations resulted in pupae lethality, indicating that the mutations are loss of function alleles [82]. A further patient identified with a compound heterozygous mutation (T265M and A582V) presented with severe anaemia, lactic acidosis and developmental delay ( Table 1) [83]. The T265M mutation is not in a known Tom70 domain, where the A582V mutation is in a TPR domain, potentially affecting substrate binding of Tom70 [83,84].…”
Section: Mitochondrial Disease and The Tom Complexmentioning
confidence: 99%
See 1 more Smart Citation
“…Homozygous null drosophila models of patient mutations resulted in pupae lethality, indicating that the mutations are loss of function alleles [82]. A further patient identified with a compound heterozygous mutation (T265M and A582V) presented with severe anaemia, lactic acidosis and developmental delay ( Table 1) [83]. The T265M mutation is not in a known Tom70 domain, where the A582V mutation is in a TPR domain, potentially affecting substrate binding of Tom70 [83,84].…”
Section: Mitochondrial Disease and The Tom Complexmentioning
confidence: 99%
“…A further patient identified with a compound heterozygous mutation (T265M and A582V) presented with severe anaemia, lactic acidosis and developmental delay ( Table 1) [83]. The T265M mutation is not in a known Tom70 domain, where the A582V mutation is in a TPR domain, potentially affecting substrate binding of Tom70 [83,84]. Patient cells had reduced levels of the Tom70 dimer, and Tom70 was not detected in the TOM complex by Blue Native PAGE [83].…”
Section: Mitochondrial Disease and The Tom Complexmentioning
confidence: 99%
“…The recently discovered roles of TOM70 in many pathological contexts suggest that also mutations in the TOMM70 gene could be involved in the development of such mitochondriopathies in humans. Indeed, two recent studies reported on mutations in TOMM70 that caused neurological impairment, developmental delay, severe anemia, and lactic acidosis [ 172 , 220 ]. The clinical consequences of these mutations indicate that essential mitochondrial functions were substantially impaired.…”
Section: Tom70 In Health and Diseasementioning
confidence: 99%
“…13 In particular, patients with abnormal TOM70 function suffer from lactic acidosis. 16 By interacting with TOM70, Orf9b may induce the production of lactic acid, which has been proven to inhibit IFN-I responses. 17 Considering the critical role of IFN-I in the human antiviral response, restoration of IFN-I production in COVID-19 patients may prove to be a significantly effective therapeutic option.…”
mentioning
confidence: 99%
“… 13 In particular, patients with abnormal TOM70 function suffer from lactic acidosis. 16 By interacting with TOM70, Orf9b may induce the production of lactic acid, which has been proven to inhibit IFN-I responses. 17 …”
mentioning
confidence: 99%